Kennedy Capital Management LLC
13F filer · CIK 0000884589Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$5.65BU.S. long equity reported on 13F
Positions54156 new · 47 closed
Net flow last quarter-$198MBuys minus sells
Top 10 positions weight9.7%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 2026541 positions | |||||
| $72.4M | 1.28% | 0.99% | +0.4% | Q1 2014 | |
| $62.8M | 1.11% | 0.56% | -24.3% | Q2 2013 | |
| $62.7M | 1.11% | 1.60% | -3.8% | Q2 2017 | |
| $62.4M | 1.11% | 0.76% | +12.4% | Q1 2026 | |
| $55M | 0.97% | 3.46% | -15.1% | Q2 2015 | |
| $48M | 0.85% | 0.37% | -24.2% | Q4 2020 | |
| $47.7M | 0.84% | 0.58% | +14.1% | Q1 2014 | |
| $47.2M | 0.84% | 0.48% | +41.7% | Q4 2025 | |
| $46.4M | 0.82% | 1.19% | -37.7% | Q2 2018 | |
| $45.7M | 0.81% | 0.64% | +1.9% | Q4 2018 | |
| $44.2M | 0.78% | 0.72% | -10.4% | Q4 2017 | |
| $42.7M | 0.76% | 0.48% | +12.5% | Q2 2015 | |
| $42.4M | 0.75% | 0.23% | -29.7% | Q3 2023 | |
| $41.5M | 0.74% | 0.75% | +84.2% | Q3 2018 | |
| $40.1M | 0.71% | 0.47% | -14.8% | Q2 2013 | |
| $40.1M | 0.71% | 0.96% | -56.0% | Q4 2016 | |
| $37.6M | 0.67% | 0.35% | +0.2% | Q2 2013 | |
| $37.6M | 0.67% | 0.30% | -13.3% | Q1 2022 | |
| $37.3M | 0.66% | 1.87% | +12.9% | Q3 2014 | |
| $36.8M | 0.65% | 0.45% | +27.3% | Q3 2017 | |
| $35.7M | 0.63% | 0.77% | -2.8% | Q2 2013 | |
| $34.4M | 0.61% | 0.36% | +78.3% | Q2 2014 | |
| $34.4M | 0.61% | Not reported | -2.6% | Q3 2018 | |
| $34.3M | 0.61% | 2.17% | -4.7% | Q2 2018 | |
| $33.4M | 0.59% | 0.31% | -1.4% | Q2 2013 | |
| $33.1M | 0.59% | 1.18% | -4.2% | Q2 2015 | |
| $33M | 0.58% | 1.96% | -2.2% | Q3 2014 | |
| $32.5M | 0.58% | Not reported | -8.8% | Q4 2017 | |
| $32.2M | 0.57% | 1.03% | -7.7% | Q2 2013 | |
| $32M | 0.57% | 0.71% | +6.8% | Q3 2017 | |
| $31.7M | 0.56% | 2.22% | +8.3% | Q1 2025 | |
| $31.6M | 0.56% | 1.16% | -5.0% | Q1 2021 | |
| $31.3M | 0.55% | 0.24% | -2.3% | Q3 2023 | |
| $30.6M | 0.54% | 0.67% | -34.7% | Q4 2022 | |
| $30M | 0.53% | 0.60% | +23.0% | Q1 2018 | |
| $29.6M | 0.52% | 1.50% | -2.6% | Q2 2013 | |
| $29.4M | 0.52% | 0.31% | +55.1% | Q1 2018 | |
| $28.8M | 0.51% | 2.43% | -2.5% | Q2 2014 | |
| $28.8M | 0.51% | 2.05% | +16.5% | Q2 2013 | |
| $28.7M | 0.51% | 0.46% | +122.5% | Q4 2021 | |
| $27.2M | 0.48% | 0.18% | +154.4% | Q4 2013 | |
| $27.1M | 0.48% | 0.31% | +2.4% | Q3 2016 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $26.9M | 0.48% | 0.70% | -28.6% | Q3 2015 |
| $26.5M | 0.47% | 1.41% | +4.0% | Q1 2014 | |
| $26.5M | 0.47% | Not reported | +29.3% | Q2 2013 | |
| $25.9M | 0.46% | 1.01% | +39.5% | Q2 2018 | |
| $25.9M | 0.46% | 0.37% | +1.9% | Q3 2018 | |
| $25.8M | 0.46% | Not reported | -1.7% | Q1 2014 | |
| $25.8M | 0.46% | 0.49% | +89.8% | Q2 2013 | |
| $25.6M | 0.45% | 0.89% | +20.8% | Q2 2013 | |
| Q1 2026Reported May 13, 2026532 positions | |||||
| $57.4M | 1.22% | 0.74% | -12.2% | Q2 2013 | |
| $56.9M | 1.21% | 4.04% | -12.6% | Q2 2015 | |
| $43M | 0.91% | 0.99% | -12.1% | Q1 2014 | |
| $40.3M | 0.85% | 1.66% | -17.0% | Q2 2017 | |
| $39.7M | 0.84% | 0.34% | -6.6% | Q2 2013 | |
| $38.8M | 0.82% | 0.35% | +31.5% | Q1 2022 | |
| $37.8M | 0.80% | 2.34% | -9.0% | Q4 2016 | |
| $37M | 0.78% | 1.10% | -4.9% | Q2 2013 | |
| $36.2M | 0.77% | 0.63% | +4.8% | Q4 2018 | |
| $35.9M | 0.76% | 0.31% | -15.8% | Q2 2013 | |
| $35M | 0.74% | 0.55% | -23.4% | Q2 2013 | |
| $34.1M | 0.72% | 0.51% | Not reported | Q1 2014 | |
| $33.2M | 0.70% | 1.66% | +9.8% | Q3 2014 | |
| $32.6M | 0.69% | 0.32% | -13.5% | Q3 2023 | |
| $32.4M | 0.69% | 0.35% | -1.1% | Q2 2013 | |
| $32.2M | 0.68% | 0.30% | +1.4% | Q3 2016 | |
| $31.4M | 0.66% | 0.68% | New | Q1 2026 | |
| $31.3M | 0.66% | 0.41% | +11.7% | Q2 2015 | |
| $31.1M | 0.66% | Not reported | -8.5% | Q3 2018 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $29.7M | 0.63% | 0.98% | -0.8% | Q3 2015 |
| $29.7M | 0.63% | 0.79% | -1.3% | Q2 2013 | |
| $29.4M | 0.62% | 1.82% | +2.6% | Q2 2021 | |
| $29.1M | 0.62% | 2.27% | -0.5% | Q2 2018 | |
| $28.8M | 0.61% | 0.34% | +13.5% | Q4 2025 | |
| $28.7M | 0.61% | 0.49% | +1928.6% | Q4 2020 | |
| $27.3M | 0.58% | 0.36% | +6.3% | Q3 2017 | |
| $27.2M | 0.58% | 0.52% | New | Q1 2026 | |
| $27.2M | 0.58% | 0.88% | +5.1% | Q1 2021 | |
| $27M | 0.57% | 2.00% | +16.6% | Q3 2014 | |
| $26.8M | 0.57% | 1.53% | +35.3% | Q2 2013 | |
| $26.2M | 0.56% | 0.71% | -1.2% | Q2 2013 | |
| $25.8M | 0.55% | 1.04% | -4.5% | Q4 2013 | |
| $25.6M | 0.54% | 2.46% | +0.1% | Q2 2014 | |
| $25.3M | 0.54% | 0.84% | -4.2% | Q1 2023 | |
| $25M | 0.53% | Not reported | -29.6% | Q4 2017 | |
| $24.8M | 0.53% | 1.03% | +135.7% | Q4 2022 | |
| $24.6M | 0.52% | 0.25% | -8.9% | Q3 2023 | |
| $24M | 0.51% | 0.80% | +0.8% | Q4 2017 | |
| $23.8M | 0.50% | 1.65% | -0.4% | Q3 2013 | |
| $23.8M | 0.50% | 1.36% | +16.3% | Q1 2014 | |
| $23.6M | 0.50% | 0.35% | -37.6% | Q4 2014 | |
| $23.6M | 0.50% | 0.41% | -3.6% | Q2 2013 | |
| $23.4M | 0.50% | 0.44% | -21.4% | Q2 2013 | |
| $23.4M | 0.49% | 0.14% | -23.1% | Q1 2014 | |
| $23.2M | 0.49% | 0.66% | +48.3% | Q3 2017 | |
| $22.7M | 0.48% | 1.24% | -28.9% | Q2 2015 | |
| $22.7M | 0.48% | 0.74% | -7.0% | Q3 2018 | |
| $22.6M | 0.48% | 1.31% | +37.5% | Q3 2013 | |
| $22.3M | 0.47% | Not reported | -2.0% | Q1 2014 | |
| $21.9M | 0.46% | 0.29% | +81.8% | Q2 2013 | |
| Q4 2025Reported Feb 13, 2026527 positions | |||||
| $65.9M | 1.40% | 0.83% | +47.9% | Q2 2013 | |
| $63.5M | 1.34% | 4.57% | +9.7% | Q2 2015 | |
| $50.9M | 1.08% | 2.01% | -10.6% | Q2 2017 | |
| $49M | 1.04% | 1.13% | +2.1% | Q1 2014 | |
| $48.1M | 1.02% | 0.37% | -2.8% | Q2 2013 | |
| $43M | 0.91% | 0.37% | +0.3% | Q2 2013 | |
| $38.6M | 0.82% | 0.72% | -15.6% | Q2 2013 | |
| $37.5M | 0.79% | 1.16% | +43.4% | Q2 2013 | |
| $34.1M | 0.72% | Not reported | +6.1% | Q3 2018 | |
| $33.1M | 0.70% | 1.68% | +0.1% | Q3 2013 | |
| $33M | 0.70% | 0.35% | +7.3% | Q2 2013 | |
| $32.8M | 0.70% | 0.60% | +6.7% | Q4 2018 | |
| RREVGREV Group, Inc. | $31.5M | 0.67% | 1.06% | +1.2% | Q3 2017 |
| $31.4M | 0.66% | Not reported | +11.9% | Q2 2013 | |
| $30.7M | 0.65% | 1.52% | +16.2% | Q3 2014 | |
| $30.7M | 0.65% | 0.56% | +16.4% | Q2 2013 | |
| $29.2M | 0.62% | 0.37% | +13.1% | Q2 2015 | |
| $29.1M | 0.62% | 0.27% | +0.5% | Q3 2023 | |
| $29M | 0.62% | 0.38% | +237.7% | Q3 2023 | |
| $28.9M | 0.61% | Not reported | +98.2% | Q4 2017 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $28.2M | 0.60% | 0.99% | +14.1% | Q3 2015 |
| $28.2M | 0.60% | 0.29% | New | Q4 2025 | |
| $26.6M | 0.56% | 0.55% | +12.3% | Q3 2018 | |
| $26.6M | 0.56% | 2.28% | +13.5% | Q2 2018 | |
| $25.9M | 0.55% | 0.72% | +14.2% | Q2 2013 | |
| $25.8M | 0.55% | 0.80% | +13.8% | Q2 2013 | |
| APAVDLAvadel Pharmaceuticals PLC | $25.7M | 0.55% | 1.22% | -26.6% | Q1 2023 |
| $25.4M | 0.54% | 0.34% | +47.5% | Q3 2017 | |
| $24.9M | 0.53% | 0.48% | +11.8% | Q1 2020 | |
| $24.9M | 0.53% | 1.75% | -8.8% | Q2 2015 | |
| $24.8M | 0.52% | 0.30% | +66.2% | Q3 2016 | |
| $24.7M | 0.52% | 2.41% | +15.9% | Q2 2014 | |
| $24.5M | 0.52% | 0.31% | +41.2% | Q1 2018 | |
| $24.5M | 0.52% | 1.38% | -39.6% | Q1 2023 | |
| $24.4M | 0.52% | 0.45% | -0.5% | Q1 2018 | |
| $24.3M | 0.51% | 0.37% | +7.8% | Q1 2016 | |
| $24.2M | 0.51% | 0.42% | +27.1% | Q2 2013 | |
| $24.1M | 0.51% | 1.80% | -12.9% | Q2 2013 | |
| $24M | 0.51% | 1.78% | +15.2% | Q2 2021 | |
| $23.6M | 0.50% | 0.87% | Not reported | Q1 2023 | |
| TBLDTopBuild Corp | $23.5M | 0.50% | 0.20% | -9.7% | Q3 2015 |
| $23.4M | 0.50% | 1.18% | +11.0% | Q1 2014 | |
| $23.4M | 0.50% | 0.18% | -0.1% | Q1 2014 | |
| $23.3M | 0.49% | 1.00% | +18.3% | Q1 2021 | |
| $23M | 0.49% | 0.21% | -16.0% | Q2 2013 | |
| $22.7M | 0.48% | 0.00% | -28.1% | Q1 2024 | |
| $22.7M | 0.48% | 1.72% | +13.0% | Q3 2014 | |
| $22.6M | 0.48% | 0.43% | +33.0% | Q3 2025 | |
| $21.8M | 0.46% | 0.26% | +13.1% | Q1 2022 | |
| $21.8M | 0.46% | 0.29% | -0.1% | Q3 2024 | |
| Q3 2025Reported Nov 13, 2025552 positions | |||||
| $53.2M | 1.18% | 2.24% | +7.8% | Q2 2017 | |
| $52.5M | 1.16% | 4.12% | +108.2% | Q2 2015 | |
| $50.9M | 1.12% | 1.11% | +23.8% | Q1 2014 | |
| $44.9M | 0.99% | 0.38% | -3.5% | Q2 2013 | |
| $42.9M | 0.95% | 0.56% | -5.9% | Q2 2013 | |
| $39.5M | 0.87% | 2.29% | Not reported | Q1 2023 | |
| $35.6M | 0.79% | Not reported | -8.4% | Q3 2018 | |
| $35.5M | 0.79% | 0.55% | -3.1% | Q4 2018 | |
| $35.2M | 0.78% | 0.84% | +343.0% | Q2 2013 | |
| $30.1M | 0.67% | 1.92% | +0.9% | Q2 2013 | |
| $30.1M | 0.66% | 1.31% | -6.9% | Q3 2014 | |
| $29.5M | 0.65% | 1.68% | +36.2% | Q3 2013 | |
| $29.1M | 0.64% | 0.33% | -9.2% | Q2 2013 | |
| RREVGREV Group, Inc. | $29M | 0.64% | 1.05% | -20.8% | Q3 2017 |
| $28.9M | 0.64% | 0.27% | +6.5% | Q3 2023 | |
| $28.6M | 0.63% | Not reported | +19.7% | Q2 2013 | |
| $28.1M | 0.62% | 0.33% | -7.6% | Q2 2015 | |
| $28.1M | 0.62% | 0.36% | +44.6% | Q2 2013 | |
| $27.6M | 0.61% | 1.92% | +18.4% | Q2 2015 | |
| $26.9M | 0.59% | 0.48% | -10.5% | Q2 2013 | |
| $26.4M | 0.58% | 0.84% | +39.6% | Q1 2021 | |
| $26.1M | 0.58% | 1.88% | +31.9% | Q2 2018 | |
| $26.1M | 0.58% | 0.81% | +131.2% | Q2 2013 | |
| $25.5M | 0.56% | 0.19% | -6.6% | Q2 2013 | |
| $25.4M | 0.56% | 0.34% | -11.2% | Q1 2016 | |
| APAVDLAvadel Pharmaceuticals PLC | $24.8M | 0.55% | 1.67% | +65.8% | Q1 2023 |
| TBLDTopBuild Corp | $24.4M | 0.54% | 0.22% | -10.9% | Q3 2015 |
| $23.4M | 0.52% | 0.31% | +100.3% | Q2 2013 | |
| $23.3M | 0.51% | 0.49% | +10.5% | Q3 2018 | |
| $23.2M | 0.51% | 1.06% | +10.0% | Q1 2014 | |
| $23.1M | 0.51% | 0.70% | -18.5% | Q2 2013 | |
| $23M | 0.51% | 0.45% | +17.5% | Q1 2018 | |
| $22.9M | 0.51% | 0.42% | +33.9% | Q1 2020 | |
| $22.9M | 0.51% | 0.08% | -13.2% | Q2 2013 | |
| $22.5M | 0.50% | 0.00% | -18.7% | Q1 2024 | |
| $21.9M | 0.48% | 0.22% | -18.9% | Q1 2022 | |
| $21.8M | 0.48% | 0.37% | +46.1% | Q2 2023 | |
| $21.6M | 0.48% | 0.63% | -8.4% | Q2 2013 | |
| $21.5M | 0.47% | 1.99% | +1.2% | Q2 2018 | |
| $21.2M | 0.47% | 0.26% | -7.6% | Q2 2013 | |
| $21.1M | 0.47% | 0.63% | +57.4% | Q2 2018 | |
| $21M | 0.46% | 0.36% | +83.6% | Q2 2013 | |
| $21M | 0.46% | 0.29% | +44.2% | Q2 2025 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $20.9M | 0.46% | 0.86% | +5.0% | Q3 2015 |
| $20.9M | 0.46% | 0.32% | New | Q3 2025 | |
| $20.4M | 0.45% | Not reported | +13.5% | Q1 2014 | |
| $20.2M | 0.45% | 0.14% | -12.2% | Q4 2024 | |
| $20.1M | 0.44% | 0.12% | -17.7% | Q3 2018 | |
| $20.1M | 0.44% | 0.57% | +14.2% | Q2 2013 | |
| $19.6M | 0.43% | 0.18% | -6.8% | Q3 2019 | |
Premium opens every quarter this fund has filed